Publications by authors named "Eleanor I Pickering"
Background: Direct-acting antivirals (DAAs) offer an unprecedented opportunity to eliminate hepatitis C virus (HCV) infection, yet barriers among people who inject drugs (PWID) remain. Having pharmacists provide care through collaborative drug therapy agreements (CDTAs) offers a promising solution. We developed and piloted a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) which utilized pharmacists to directly deliver HCV care at community organizations serving PWID.
View Article and Find Full Text PDFArticle Synopsis
- HIV rates among people who inject drugs (PWID) in the USA have been increasing since 2014, highlighting the need to better engage this group in HIV prevention services like pre-exposure prophylaxis (PrEP).
- A study involving interviews and focus groups with PWID showed that many had limited knowledge of PrEP and expressed little concern for HIV risk, mostly viewing sexual behavior as the primary risk factor rather than injection drug use.
- Participants identified several barriers to accessing PrEP, including a lack of community discussions about HIV, misconceptions about its use, and various personal and environmental challenges that make starting PrEP difficult.